Drug Shortage Report for APO-DICLO

Last updated on 2023-04-21 History
Report ID 182361
Drug Identification Number 00839183
Brand name APO-DICLO
Common or Proper name DICLOFENAC
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) DICLOFENAC SODIUM
Strength(s) 50MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-01-24
Estimated end date 2023-04-21
Actual end date 2023-04-20
Shortage status Resolved
Updated date 2023-04-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2023-04-21 French Compare
v9 2023-04-21 English Compare
v8 2023-03-23 French Compare
v7 2023-03-23 English Compare
v6 2023-03-09 French Compare
v5 2023-03-09 English Compare
v4 2023-02-02 French Compare
v3 2023-02-02 English Compare
v2 2023-01-26 French Compare
v1 2023-01-26 English Compare

Showing 1 to 10 of 10